Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Metformin Plus Insulin on Non-obese Autoimmune Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating metformin in combination with insulin for non-obese autoimmune diabetes (Type 1 diabetes with autoimmune component).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • metformin (metformin)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Type 1 Diabetes Mellitus, Autoimmune Diabetes | Phase 4 | Status: UNKNOWN